Search

Copper nanoparticles (Cu‐NPs) have garnered substantial interest in the field of nanotechnology due to their exceptional physical and chemical properties and cost‐effectiveness. However, challenges such as particle aggregation and rapid copper oxidation affect nanoscale production. This study systematically investigates the synthesis of colloidal Cu‐NPs using chitosan (Cts) as a stabilizer and reducing agent in the arc discharge system, comparing it to distilled water as a medium. Confirmation of the purity, size, and morphology of the Cu‐NPs is achieved through various physicochemical characterization methods. X‐ray diffraction patterns confirm the synthesis of highly pure face‐centered cubic (fcc) crystal Cu‐NPs. UV–vis analysis reveals absorption peaks at 572–585 nm, indicating pure copper. Fourier‐transform infrared spectroscopy shows peaks at 638 and 597 cm−1, corresponding to Cu─Cts bonds. Transmission electron microscopy images depict spherical nanoparticles ranging from 15 to 45 nm, with smaller sizes at higher Cts concentrations. The catalytic activity of Cu‐NPs in the degradation of 4‐nitrophenol to 4‐aminophenol is assessed, with Cu‐NPs synthesized in distilled water demonstrating superior catalytic properties compared to 0.10 wt.% Cts. This study highlights the efficacy of the arc discharge method in producing pure, uniformly sized Cu‐NPs with potential applications in catalysis. [ABSTRACT FROM AUTHOR]

In this study, zinc oxide nanoparticles (ZnO‐NPs) are synthesized and combined with chitosan (Cs) to create Cs/ZnO‐NPs nanomicelles, aiming to investigate their potential as a novel cancer treatment. The ZnO‐NPs are produced through a sintering process at temperatures ranging from 300 to 700 °C. The most effective nanoparticles are obtained at 600 °C, as determined by X‐ray diffraction (XRD) and Fourier‐transform infrared spectroscopy (FTIR) analyses, which confirmed their crystallinity and purity. Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) are employed to characterize the size and shape of the nanoparticles, revealing predominantly spherical and hexagonal structures with stable dimensions. The cytotoxic effects of the Cs/ZnO‐NPs are evaluated against various cancer cell types. The results show that at a concentration of 125 µg mL−1, the Cs/ZnO‐NPs demonstrate significantly higher cancer cell toxicity compared to ZnO‐NPs alone, while remaining non‐toxic to normal cells. This indicates that Cs/ZnO‐NPs have a superior ability to selectively target cancer cells. These findings suggest that Cs/ZnO‐NPs nanomicelles hold promise as an effective and safe nanotherapeutic approach in the realm of cancer treatment, meriting further exploration for clinical applications. [ABSTRACT FROM AUTHOR]

Review: 129 refs. [ABSTRACT FROM AUTHOR]